An educational intervention to improve adverse drug reactions reporting: a cluster-randomised trial among Portuguese physicians and pharmacists

Not Applicable

Completed

• Conditions: nder-reporting of adverse drug reactions; Not Applicable

• Registration Number: ISRCTN45894687
• Lead Sponsor: Educational Development Program for Portugal (Programa de Desenvolvimento Educativo para Portugal) (PRODEP) (Portugal)

Brief Summary

2008 results in: https://www.ncbi.nlm.nih.gov/pubmed/18366244 (added 11/07/2019)

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2005-06-30
• Study Start: 2006-06-15
• Last Update Posted: 29 July 2019

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 1433

Inclusion Criteria

All National Health System physicians working in the Northern Region of Portugal and all pharmacists working in the same geographical area.

Exclusion Criteria

Physicians not involved in any clinical activity (e.g. engaged in administrative tasks, analysis, etc.); working in substance abuse and rehabilitation centers; working at the regional pharmacosurveillance center or any department having a specific voluntary adverse drug reaction reporting program and physicians attached to specific hospitals (cancer, maternity, etc). Pharmacists working at the regional pharmacosurveillance center and attached to specific hospitals (cancer, maternity, etc).

Study & Design

• Study Type: Interventional
• Study Design: Not specified